ApprovalTrail

Drug · DIN 02498413

CLINIMIX E

8% AMINO ACIDS (BLEND D) WITH ELECTROLYTES IN 10% DEXTROSE WITH CALCIUM INJECTION

Yes: authorized and sold in Canada

Authorized, and the company reports that it sells it in Canada.

Status Marketed since October 1, 2021; first marketed October 1, 2021.
Drug Identification Number (DIN)
02498413
Company (DIN owner)
Baxter CorporationMississauga, Ontario, Canada
Schedule
Ethical
Dosage form
Solution
Route
Intravenous
Therapeutic class (ATC)
Combinations B05BA10
Class
Human
Record last updated
March 22, 2025

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
ALANINE1656 MG100 ML
L-ARGININE920 MG100 ML
GLYCINE824 MG100 ML
HISTIDINE384 MG100 ML
L-ISOLEUCINE480 MG100 ML
L-LEUCINE584 MG100 ML
L-LYSINE HYDROCHLORIDE464 MG100 ML
METHIONINE320 MG100 ML
L-PHENYLALANINE448 MG100 ML
L-PROLINE544 MG100 ML
SERINE400 MG100 ML
L-THREONINE336 MG100 ML
TRYPTOPHAN144 MG100 ML
L-TYROSINE32 MG100 ML
L-VALINE464 MG100 ML
DEXTROSE10 G100 ML
SODIUM CHLORIDE205 MG100 ML
POTASSIUM PHOSPHATE DIBASIC261 MG100 ML
MAGNESIUM CHLORIDE24 MG100 ML
CALCIUM CHLORIDE33 MG100 ML

Notices of Compliance

Health Canada approvals that name this DIN.

Other DINs named CLINIMIX E